FGF-4 Antibodies

Santa Cruz Biotechnology delivers a wide array of FGF-4 monoclonal antibodies for research focused on understanding Fibroblast Growth Factor 4. FGF-4 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Fibroblast Growth Factor 4 plays an essential role in developmental processes, particularly in limb and organ formation. FGF-4 actively participates in cellular proliferation, differentiation, and survival, making it vital for tissue repair and regeneration. Research has shown that FGF-4 signaling pathways influence embryonic development and stem cell maintenance. Understanding FGF-4 mechanisms can reveal potential therapeutic approaches for developmental disorders and regenerative medicine. Investigating FGF-4 functions continues to uncover new insights into growth factor signaling networks. Recent studies highlight FGF-4's significance in maintaining pluripotency in embryonic stem cells. Santa Cruz Biotechnology monoclonal antibodies for FGF-4 enable researchers worldwide to advance scientific understanding of growth factor biology and its therapeutic applications.